Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

4(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

10%

Ph phase_2

20%

Ph phase_3

50%

Ph phase_1

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

2(22.2%)

Phase 3Large-scale testing

5(55.6%)

Phase 4Post-market surveillance

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(8)

Completed(2)

Detailed Status

Not yet recruiting4

Active, not recruiting3

Completed2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 22 (22.2%)

Phase 35 (55.6%)

Phase 41 (11.1%)

Trials by Status

recruiting110%

not_yet_recruiting440%

completed220%

active_not_recruiting330%

Recent Activity

4 active trials

Showing 5 of 10

completedphase_3

A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

NCT06649344

not_yet_recruitingphase_3

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

NCT07653477

active_not_recruitingphase_2

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

NCT07073417

recruitingphase_1

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

NCT07465965

active_not_recruitingphase_3

A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity

NCT07285902

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT06649344Phase 3

A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

Completed

NCT07653477Phase 3

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Not Yet Recruiting

NCT07073417Phase 2

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Active Not Recruiting

NCT07465965Phase 1

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Recruiting

NCT07285902Phase 3

A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity

Active Not Recruiting

NCT06577090Phase 2

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo